Gemmel, C <br/><br/>
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation.  [electronic resource] 

 -  Annals of hematology  Feb 2002 
 - 119-23 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0939-5555 
<br/><br/><label>Standard No.: </label>10.1007/s00277-001-0397-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Combined Modality Therapy<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Leukemia, Plasma Cell--therapy<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Rituximab<br/>Transplantation, Autologous